Jared Weiss, MD, associate professor of medicine in the division of oncology, commented on one of two treatment regimens that have shown promise for treating elderly or frail patients with head and neck squamous cell carcinoma, according to researchers.
“These results are consistent with those observed in the dose-escalation part of the study and suggest durable efficacy,” said Jared Weiss, MD, referring to the nanoparticle NBTXR3 followed by radiotherapy.
“This nanoparticle along with radiotherapy also appears to work with immunotherapy. If large studies confirm the results seen thus far, this is a winner. It looks like the mechanism of action is broadly applicable,” Weiss added.
Read the article in Cancer Therapy Advisor.